Ophthal Medical News about Macular Edema

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion
Archives of Ophthalmology, 09/17/09

Intravitreal triamcinolone is superior to observation for treating vision loss associated with macular edema secondary to CRVO in patients who have characteristics similar to those in the SCORE–CRVO trial. The 1–mg dose has a safety profile superior to that of the 4–mg dose.

<< Previous
A Randomized Trial Comparing the Efficacy and Safety of...

Next >>
The Relation of Markers of Inflammation and Endothelial...

Bevacizumab Improves Macular Edema
Review of Ophthalmology, 10/02/09 Relevance Score: 69%

Pars plana vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion
European Journal of Ophthalmology, 11/13/09 Relevance Score: 68%

Is multifocal ERG a reliable index of macular function after triamcinolone acetonide injection in diffuse diabetic macular edema
European Journal of Ophthalmology, 11/11/09 Relevance Score: 68%

Pegaptanib Sodium for Macular Edema Secondary to Branch Retinal Vein Occlusion
American Journal of Ophthalmology, 10/30/09 Relevance Score: 68%

Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions
Retina, 11/17/09 Relevance Score: 66%